Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Diseases

  Free Subscription


Articles published in Biochem Biophys Res Commun

Retrieve available abstracts of 272 articles:
HTML format



Single Articles


    December 2024
  1. HAO YY, Xiao WQ, Zhang HN, Yu NN, et al
    Peroxiredoxin 1 modulates oxidative stress resistance and cell apoptosis through stemness in liver cancer under non-thermal plasma treatment.
    Biochem Biophys Res Commun. 2024;738:150522.
    PubMed     Abstract available


  2. GONG X, Liu Y, Liang K, Chen Z, et al
    Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization.
    Biochem Biophys Res Commun. 2024;738:150508.
    PubMed     Abstract available


  3. WU J, Liu F, Guo X, Cui C, et al
    FASN promotes anoikis resistance in colorectal liver metastases through the ERK1/2 pathway.
    Biochem Biophys Res Commun. 2024;736:150494.
    PubMed     Abstract available


    November 2024
  4. LEE J, Hong SW, Kim MJ, Lim YM, et al
    Sodium-glucose cotransporter 2 inhibitors ameliorate ER stress-induced pro-inflammatory cytokine expression by inhibiting CD36 in NAFLD progression in vitro.
    Biochem Biophys Res Commun. 2024;735:150620.
    PubMed     Abstract available


  5. DU Y, Zhang H, Liu J, Duan X, et al
    HK3: A potential prognostic biomarker with metastasis inhibition capabilities in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2024;741:151057.
    PubMed     Abstract available


  6. XU X, Wang Y, Wu X, Cai T, et al
    Administration of Alistipes indistinctus prevented the progression from nonalcoholic fatty liver disease to nonalcoholic steatohepatitis by enhancing the gut barrier and increasing Lactobacillus spp.
    Biochem Biophys Res Commun. 2024;741:151033.
    PubMed     Abstract available


  7. LI C, Chen X, Wu J, Heng S, et al
    High-throughput screening identified pacritinib as a promising therapeutic approach to overcome lenvatinib resistance in hepatocellular carcinoma by targeting IRAK1.
    Biochem Biophys Res Commun. 2024;734:150782.
    PubMed     Abstract available


  8. YAMAUCHI Y, Mieno H, Suetsugu H, Watanabe H, et al
    Elevated PRELP expression in heart and liver fibrosis promotes collagen production.
    Biochem Biophys Res Commun. 2024;734:150785.
    PubMed     Abstract available


  9. ZHAI F, Wang J, Wan X, Liu Y, et al
    Dual anti-inflammatory effects of curcumin and berberine on acetaminophen-induced liver injury in mice by inhibiting NF-kappaB activation via PI3K/AKT and PPARgamma signaling pathways.
    Biochem Biophys Res Commun. 2024;734:150772.
    PubMed     Abstract available


  10. LIU X, Liu T, Zhou Z, Bian K, et al
    Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway.
    Biochem Biophys Res Commun. 2024;734:150762.
    PubMed     Abstract available


  11. SHAHI A, Yadav A, Rajak S, Raza S, et al
    Liver-specific thyroid hormone receptor-beta agonism alleviates alcoholic steatohepatitis (ASH) in mice.
    Biochem Biophys Res Commun. 2024;734:150742.
    PubMed     Abstract available


  12. LI YN, Sun FF, Ouyang F, Luo D, et al
    Alterations in liver triglyceride profiles in CCl(4)-induced liver regeneration.
    Biochem Biophys Res Commun. 2024;734:150662.
    PubMed     Abstract available


  13. GAO G, Zhang Z, Wang Q, Xie Z, et al
    A peptide alleviated oxidative damages in the L02 cells and mice liver.
    Biochem Biophys Res Commun. 2024;734:150643.
    PubMed     Abstract available


  14. MAO D, Guo J, Yang K, Yang F, et al
    Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation.
    Biochem Biophys Res Commun. 2024;734:150424.
    PubMed     Abstract available


  15. TSUCHIYA Y, Nishina T, Komazawa-Sakon S, Seki T, et al
    Interleukin-11 signaling plays limited roles for liver fibrosis in a mouse model of metabolic dysfunction-associated steatohepatitis.
    Biochem Biophys Res Commun. 2024;739:150938.
    PubMed     Abstract available


    October 2024
  16. HU L, Yuan D, Zhu Q, Wu M, et al
    Evaluation of the role of hepatic Gstm4 in diet-induced obesity and dyslipidemia.
    Biochem Biophys Res Commun. 2024;737:150920.
    PubMed     Abstract available


  17. EL-ZEHERY IM, El-Mesery M, El-Sherbiny M, El Gayar AM, et al
    Carbenoxolone upregulates TRAIL\TRAILR2 expression and enhances the anti-neoplastic effect of doxorubicin in experimentally induced hepatocellular carcinoma in rats.
    Biochem Biophys Res Commun. 2024;741:150876.
    PubMed     Abstract available


  18. AHN SH, Lee YJ, Lim DS, Cho W, et al
    Upadacitinib counteracts hepatic lipid deposition via the repression of JAK1/STAT3 signaling and AMPK/autophagy-mediated suppression of ER stress.
    Biochem Biophys Res Commun. 2024;735:150829.
    PubMed     Abstract available


  19. GULZAR F, Chhikara N, Kumar P, Ahmad S, et al
    ER stress aggravates NOD1-mediated inflammatory response leading to impaired nutrient metabolism in hepatoma cells.
    Biochem Biophys Res Commun. 2024;735:150827.
    PubMed     Abstract available


    September 2024
  20. CHEN Y, Zhang Y, Jin X, Hong S, et al
    Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2024;726:150305.
    PubMed     Abstract available


  21. YU T, Wang L, Cheng Y, Zhang Y, et al
    Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy.
    Biochem Biophys Res Commun. 2024;726:150264.
    PubMed     Abstract available


  22. MA ZJ, Yue SS, Qin BY, Hu YT, et al
    Naringenin ameliorates MASH fibrosis via regulating TAK1/MAPK/FoxO3a-mediated apoptosis in the activated hepatic stellate cells.
    Biochem Biophys Res Commun. 2024;734:150732.
    PubMed     Abstract available


  23. CHOI MS, Hong JS, Lee DH, Lee YS, et al
    MicroRNA miR-199a-3p alleviates liver fibrosis by targeting CDK17 in activated hepatic stellate cells.
    Biochem Biophys Res Commun. 2024;733:150727.
    PubMed     Abstract available


  24. SHEN J, Wu Z, Zhou Y, Yang D, et al
    Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis.
    Biochem Biophys Res Commun. 2024;733:150709.
    PubMed     Abstract available


  25. MALHEIRO LFL, Oliveira CA, Portela FS, Merces EAB, et al
    High-intensity interval training alleviates liver inflammation by regulating the TLR4/NF-kappaB signaling pathway and M1/M2 macrophage balance in female rats with cisplatin hepatotoxicity.
    Biochem Biophys Res Commun. 2024;733:150712.
    PubMed     Abstract available


  26. SON HK, Jhun H, Lee HB, Lee YR, et al
    Influence of different types of dietary sugars on the intestinal mucosa and hepatic lipid metabolism in germ-free mice.
    Biochem Biophys Res Commun. 2024;733:150707.
    PubMed     Abstract available


    August 2024
  27. HE Y, Wu S, Chen L, Chen W, et al
    Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2024;734:150633.
    PubMed     Abstract available


  28. YAMAGATA K, Takasuga S, Tatematsu M, Fuchimukai A, et al
    FoxD1 expression identifies a distinct subset of hepatic stellate cells involved in liver fibrosis.
    Biochem Biophys Res Commun. 2024;734:150632.
    PubMed     Abstract available


  29. HE Y, Long K, Du B, Liao W, et al
    The cellular senescence score (CSS) is a comprehensive biomarker to predict prognosis and assess senescence and immune characteristics in hepatocellular carcinoma (HCC).
    Biochem Biophys Res Commun. 2024;739:150576.
    PubMed    


  30. LI J, Wen W, Li J, Liu T, et al
    CNOT7 regulates lipid deposition in nonalcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2024;721:150003.
    PubMed     Abstract available


  31. TOMIOKA I, Ota C, Tanahashi Y, Ikegami K, et al
    Loss of the DNA-binding domain of the farnesoid X receptor gene causes severe liver and kidney injuries.
    Biochem Biophys Res Commun. 2024;721:150125.
    PubMed     Abstract available


  32. SUN T, Li S, Li X, Lei Y, et al
    Apigenin intervenes in liver fibrosis by regulating PKM2-HIF-1alpha mediated oxidative stress.
    Biochem Biophys Res Commun. 2024;721:150130.
    PubMed     Abstract available


  33. ZHOU Y, Song XL, Guo LB, Yu XR, et al
    Avapritinib efficacy in primary hepatic neuroendocrine carcinoma with elevated PDGFRA expression: Insights from a PDX model study.
    Biochem Biophys Res Commun. 2024;736:150504.
    PubMed     Abstract available


    July 2024
  34. ZHU J, Liu Q, Nie S, Huang Y, et al
    LEPR/FOS/JUNB signaling pathway contributes to chronic restraint stress-induced tumor proliferation.
    Biochem Biophys Res Commun. 2024;719:150042.
    PubMed     Abstract available


  35. SAVOCA M, Takemoto K, Hu J, Li L, et al
    MitoTracker Red for isolation of zone-specific hepatocytes and characterization of hepatic sublobular metabolism.
    Biochem Biophys Res Commun. 2024;735:150457.
    PubMed     Abstract available


  36. MA Y, Yao X, Zou Y, Liu B, et al
    Ticlopidine protects hepatic ischemia-reperfusion injury via suppressing ferroptosis.
    Biochem Biophys Res Commun. 2024;733:150436.
    PubMed     Abstract available


  37. YANG M, Wang R, Wei L, Liu H, et al
    PLA plastic particles disrupt bile acid metabolism leading to hepatic inflammatory injury in male mice.
    Biochem Biophys Res Commun. 2024;732:150410.
    PubMed     Abstract available


  38. DROPMANN A, Alex S, Schorn K, Tong C, et al
    The TGF-beta1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects.
    Biochem Biophys Res Commun. 2024;732:150409.
    PubMed     Abstract available


  39. GWON HJ, Chung YH, Lim DS, Cho W, et al
    Uvaol ameliorates lipid deposition in hyperlipidemic hepatocytes by suppressing protein-tyrosine phosphatase 1B/ER stress signaling.
    Biochem Biophys Res Commun. 2024;730:150387.
    PubMed     Abstract available


    June 2024
  40. ZHANG S, Gao YF, Zhang K, Deng GR, et al
    Integrating network pharmacology and experimental validation reveals therapeutic effects of D-mannose on NAFLD through mTOR suppression.
    Biochem Biophys Res Commun. 2024;715:149999.
    PubMed     Abstract available


  41. YAMAMOTO T, Iizuka Y, Izumi-Yamamoto K, Shirota M, et al
    Overexpression of Slc22a18 facilitates fat accumulation in mice.
    Biochem Biophys Res Commun. 2024;712-713:149922.
    PubMed     Abstract available


  42. ERITEN B, Caglayan C, Gur C, Kucukler S, et al
    Hepatoprotective effects of zingerone on sodium arsenite-induced hepatotoxicity in rats: Modulating the levels of caspase-3/Bax/Bcl-2, NLRP3/NF-kappaB/TNF-alpha and ATF6/IRE1/PERK/GRP78 signaling pathways.
    Biochem Biophys Res Commun. 2024;725:150258.
    PubMed     Abstract available


  43. KIM DH, Kwon EJ, Park KG, Jin J, et al
    Acesulfame potassium upregulates PD-L1 in HCC cells by attenuating autophagic degradation.
    Biochem Biophys Res Commun. 2024;711:149921.
    PubMed     Abstract available


    May 2024
  44. MAO T, Zhang C, Yang S, Bi Y, et al
    Semaglutide alters gut microbiota and improves NAFLD in db/db mice.
    Biochem Biophys Res Commun. 2024;710:149882.
    PubMed     Abstract available


  45. LIU X, Liu R, Wang Y
    Indole-3-carboxaldehyde alleviates acetaminophen-induced liver injury via inhibition of oxidative stress and apoptosis.
    Biochem Biophys Res Commun. 2024;710:149880.
    PubMed     Abstract available


  46. WANG B, Zhu X, Yu S, Xue H, et al
    Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice.
    Biochem Biophys Res Commun. 2024;722:150170.
    PubMed     Abstract available


  47. SHI X, Qi Z, Huang D, Zhu J, et al
    HuR facilitates miR-93-5p-induced activation of MAP3K2 translation via MAP3K2 3'UTR ARE2 in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2024;722:150152.
    PubMed     Abstract available


  48. ZHU J, Tang W, Wu X, Mu M, et al
    Tectorigenin improves metabolic dysfunction-associated steatohepatitis by down-regulating tRF-3040b and promoting mitophagy to inhibit pyroptosis pathway.
    Biochem Biophys Res Commun. 2024;720:150118.
    PubMed     Abstract available


  49. DONG M, Zhang T, Liang X, Cheng X, et al
    Sesamin alleviates lipid accumulation induced by oleic acid via PINK1/Parkin-mediated mitophagy in HepG2 cells.
    Biochem Biophys Res Commun. 2024;708:149815.
    PubMed     Abstract available


  50. ZHENG E, Chen Q, Xiao A, Luo X, et al
    Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway.
    Biochem Biophys Res Commun. 2024;707:149781.
    PubMed     Abstract available


    April 2024
  51. HE L, Peng L, Wang L, Jiang X, et al
    Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing immunogenic cell death and damage-associated molecular patterns in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2024;714:149976.
    PubMed     Abstract available


  52. PENG J, Liang G, Li Y, Mao S, et al
    Identification of a novel FOXO3 agonist that protects against alcohol induced liver injury.
    Biochem Biophys Res Commun. 2024;704:149690.
    PubMed     Abstract available


  53. CAO Y, Wang S, Zhang M, Lai B, et al
    PFKFB3-mediated glycolysis in hepatic stellate cells promotes liver regeneration.
    Biochem Biophys Res Commun. 2024;712-713:149958.
    PubMed     Abstract available


  54. CHEN F
    Inhibiting Pink1/Parkin-mediated mitophagy enhances the anticancer effects of quercetin in hepatocellular carcinomaf.
    Biochem Biophys Res Commun. 2024;712-713:149899.
    PubMed     Abstract available


  55. WU M, Tie M, Hu L, Yang Y, et al
    Fatty liver disease protective MTARC1 p.A165T variant reduces the protein stability of MTARC1.
    Biochem Biophys Res Commun. 2024;702:149655.
    PubMed     Abstract available


    March 2024
  56. SEYAMA Y, Sudo K, Yamada T, Tsuchiya K, et al
    Ascorbic acid predominantly kills cancer stem cell-like cells in the hepatocellular carcinoma cell line Li-7 and is more effective at low cell density and in small spheroids.
    Biochem Biophys Res Commun. 2024;709:149816.
    PubMed     Abstract available


    February 2024
  57. SHANG S, Wan Q, Chen F, Hu J, et al
    Co-targeting ASK1 and THRbeta synergistically improves steatohepatitis and fibrosis in a MASH animal model.
    Biochem Biophys Res Commun. 2024;705:149739.
    PubMed     Abstract available


  58. HUANG W, Qian Y, Lin J, Wang F, et al
    Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner.
    Biochem Biophys Res Commun. 2024;705:149670.
    PubMed     Abstract available


  59. CHO W, Oh H, Abd El-Aty AM, Ozten O, et al
    Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis.
    Biochem Biophys Res Commun. 2024;703:149671.
    PubMed     Abstract available


  60. KALISHWARALAL K, Azeez Nazeer A, Induja DK, Keerthana CK, et al
    Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling.
    Biochem Biophys Res Commun. 2024;703:149648.
    PubMed     Abstract available


  61. YUAN X, Wen Y, Shi Q, Zhao Y, et al
    MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer.
    Biochem Biophys Res Commun. 2024;695:149424.
    PubMed     Abstract available


    January 2024
  62. ZHANG M, Shi X, Tang M, Yin W, et al
    PRDX2 deficiency increases MCD-induced nonalcoholic steatohepatitis in female mice.
    Biochem Biophys Res Commun. 2024;701:149589.
    PubMed     Abstract available


  63. LI C, Liang G, Yan K, Wang Y, et al
    NRF2 mutation enhances the immune escape of hepatocellular carcinoma by reducing STING activation.
    Biochem Biophys Res Commun. 2024;698:149536.
    PubMed     Abstract available


  64. JIN M, Mi Y, Li F, Ren F, et al
    ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression.
    Biochem Biophys Res Commun. 2024;696:149515.
    PubMed     Abstract available


  65. LEE S, Memon A, Chae SC, Shin D, et al
    Epcam regulates intrahepatic bile duct reconstruction in zebrafish, providing a potential model for primary cholangitis model.
    Biochem Biophys Res Commun. 2024;696:149512.
    PubMed     Abstract available


  66. BAE S, Moon YA
    Deletion of Elovl5 leads to dyslipidemia and atherosclerosis in LDLR-deficient mice.
    Biochem Biophys Res Commun. 2024;690:149292.
    PubMed     Abstract available


    December 2023
  67. ABI ZAMER B, Rah B, Jayakumar MN, Abumustafa W, et al
    DNA methylation-mediated epigenetic regulation of oncogenic RPS2 as a novel therapeutic target and biomarker in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2023;696:149453.
    PubMed     Abstract available


  68. ABDELRAHMAN BA, Hammam OA, El-Khatib AS, Attia YM, et al
    The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH.
    Biochem Biophys Res Commun. 2023;688:149122.
    PubMed     Abstract available


  69. ZHAO H, Han G, Jiang Z, Gao D, et al
    Identification of BMAL1-Regulated circadian genes in mouse liver and their potential association with hepatocellular carcinoma: Gys2 and Upp2 as promising candidates.
    Biochem Biophys Res Commun. 2023;696:149422.
    PubMed     Abstract available


  70. HORIKOSHI M, Harada K, Tsuno S, Kitaguchi T, et al
    Distinct lactate metabolism between hepatocytes and myotubes revealed by live cell imaging with genetically encoded indicators.
    Biochem Biophys Res Commun. 2023;694:149416.
    PubMed     Abstract available


  71. NAMBA N, Kuwahara T, Kondo Y, Fukusaki K, et al
    Fasudil inhibits the expression of C/EBP homologous protein to protect against liver injury in acetaminophen-overdosed mice.
    Biochem Biophys Res Commun. 2023;686:149166.
    PubMed     Abstract available


  72. CAO J, Zhong Q, Huang Y, Zhu M, et al
    Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2023;686:149180.
    PubMed     Abstract available


  73. IMAMORI M, Hosooka T, Imi Y, Hosokawa Y, et al
    Thrombospondin-1 promotes liver fibrosis by enhancing TGF-beta action in hepatic stellate cells.
    Biochem Biophys Res Commun. 2023;693:149369.
    PubMed     Abstract available


  74. QU D, Chen M, Zhu H, Liu X, et al
    Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Biochem Biophys Res Commun. 2023;684:149131.
    PubMed     Abstract available


    November 2023
  75. HE J, Han J, Lin K, Wang J, et al
    PTEN/AKT and Wnt/beta-catenin signaling pathways regulate the proliferation of Lgr5+ cells in liver cancer.
    Biochem Biophys Res Commun. 2023;683:149117.
    PubMed     Abstract available


  76. FENG R, Cheng D, Chen X, Yang L, et al
    Identification and validation of palmitoylation metabolism-related signature for liver hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2023;692:149325.
    PubMed     Abstract available


  77. HAN Q, Yan X, Wang L, Zhang N, et al
    Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism.
    Biochem Biophys Res Commun. 2023;682:259-265.
    PubMed     Abstract available


  78. SUO L, Gao M, Ma T, Gao Z, et al
    Effect of RPL27 knockdown on the proliferation and apoptosis of human liver cancer cells.
    Biochem Biophys Res Commun. 2023;682:156-162.
    PubMed     Abstract available


  79. LIN X, Pan F, Abudoureyimu M, Wang T, et al
    Aurora-A inhibitor synergistically enhances the inhibitory effect of anlotinib on hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2023;690:149247.
    PubMed     Abstract available


  80. RAMPOGU S, Badvel P, Hoon Jo B, Kim Y, et al
    A review on Millepachine and its derivatives as potential multitarget anticancer agents.
    Biochem Biophys Res Commun. 2023;681:249-270.
    PubMed     Abstract available


  81. WANG S, Yi W, Xu Z, Shi M, et al
    PYCR2 promotes growth and aerobic glycolysis in human liver cancer by regulating the AKT signaling pathway.
    Biochem Biophys Res Commun. 2023;680:15-24.
    PubMed     Abstract available


    October 2023
  82. CHEN X, Wang D, Wang Z, Huang W, et al
    Identification of pyroptosis-related genes in NASH based on bioinformatic analysis.
    Biochem Biophys Res Commun. 2023;679:90-97.
    PubMed     Abstract available


  83. ZHONG F, Wang Y
    YY1-regulated lncRNA SOCS2-AS1 suppresses HCC cell stemness and progression via miR-454-3p/CPEB1.
    Biochem Biophys Res Commun. 2023;679:98-109.
    PubMed     Abstract available


  84. JUNG M, Ji E, Kang H, Kim C, et al
    The microRNA-195-5p/hnRNP A1 axis contributes to the progression of hepatocellular carcinoma by regulating the migration of cancer cells.
    Biochem Biophys Res Commun. 2023;686:149183.
    PubMed     Abstract available


  85. JIN Q, Hu Y, Gao Y, Zheng J, et al
    Hhex and Prox1a synergistically dictate the hepatoblast to hepatocyte differentiation in zebrafish.
    Biochem Biophys Res Commun. 2023;686:149182.
    PubMed     Abstract available


  86. DARIJANI MH, Aminzadeh A, Rahimi HR, Mandegary A, et al
    Evaluating the protective effect of metformin against diclofenac-induced oxidative stress and hepatic damage: In vitro and in vivo studies.
    Biochem Biophys Res Commun. 2023;685:149168.
    PubMed     Abstract available


  87. SU H, Shu S, Tang W, Zheng C, et al
    ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression.
    Biochem Biophys Res Commun. 2023;684:149137.
    PubMed     Abstract available


  88. GHEYBI F, Khooei A, Hoseinian A, Doagooyan M, et al
    Alleviation of acetaminophen-induced liver failure using silibinin nanoliposomes: An in vivo study.
    Biochem Biophys Res Commun. 2023;676:103-108.
    PubMed     Abstract available


  89. JOUENNE A, Hamici K, Varlet I, Sourdon J, et al
    Relationship of cardiac remodeling and perfusion alteration with hepatic lipid metabolism in a prediabetic high fat high sucrose diet female rat model.
    Biochem Biophys Res Commun. 2023;682:207-215.
    PubMed     Abstract available


  90. KIM J, Choi A, Kwon YH
    Maternal low-protein diet alters hepatic lipid accumulation and gene expression related to glucose metabolism in young adult mouse offspring fed a postweaning high-fat diet.
    Biochem Biophys Res Commun. 2023;682:193-198.
    PubMed     Abstract available


  91. SUN G, Wei Y, Zhu J, Zheng S, et al
    The transcription factor T-bet promotes the pathogenesis of nonalcoholic fatty liver disease by upregulating intrahepatic inflammation.
    Biochem Biophys Res Commun. 2023;682:266-273.
    PubMed     Abstract available


  92. HANAKI Y, Shikata Y, Kikumori M, Okamura M, et al
    Invivo anti-cancer activity of 10-methyl-aplog-1, a simplified analog of aplysiatoxin, and its possible signaling pathway associated with G1 arrest.
    Biochem Biophys Res Commun. 2023;675:19-25.
    PubMed     Abstract available


    September 2023
  93. ZHENG D, Bashir M, Li Z
    ERalpha prevents tumorigenesis of both liver and breast cancer cells through CCN5.
    Biochem Biophys Res Commun. 2023;672:103-112.
    PubMed     Abstract available


  94. HAN YH, He XM, Jin MH, Sun HN, et al
    Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2023;672:36-44.
    PubMed     Abstract available


  95. ABRAHAMS Y, Willmer T, Patel O, Samodien E, et al
    A high fat, high sugar diet induces hepatic Peroxisome proliferator-activated receptor gamma coactivator 1-alpha promoter hypermethylation in male Wistar rats.
    Biochem Biophys Res Commun. 2023;680:25-33.
    PubMed     Abstract available


    August 2023
  96. NIAN F, Zhu C, Jin N, Xia Q, et al
    Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro.
    Biochem Biophys Res Commun. 2023;669:134-142.
    PubMed     Abstract available


  97. KE X, Hu H, Peng Q, Ying H, et al
    USP33 promotes nonalcoholic fatty acid disease-associated fibrosis in gerbils via the c-myc signaling.
    Biochem Biophys Res Commun. 2023;669:68-76.
    PubMed     Abstract available


  98. WANG H, Liu Y, Cui J, Tong M, et al
    Effects of Scutellaria strigillosa Hemsl. extract on HepG2 cell proliferation and apoptosis through binding to aspartate beta-hydroxylase.
    Biochem Biophys Res Commun. 2023;668:62-69.
    PubMed     Abstract available


    July 2023
  99. CHEN J, Hao Y, Xu P, Bian D, et al
    CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2023;667:120-126.
    PubMed     Abstract available


  100. WANG Z, Huang Y, Zhu M, Cao J, et al
    TLR2 and CASP7 as the biomarkers associated with non-alcoholic fatty liver disease and chronic kidney disease.
    Biochem Biophys Res Commun. 2023;667:50-57.
    PubMed     Abstract available


  101. AKI T, Tanaka H, Funakoshi T, Unuma K, et al
    Excessive N-acetylcysteine exaggerates glutathione redox homeostasis and apoptosis during acetaminophen exposure in Huh-7 human hepatoma cells.
    Biochem Biophys Res Commun. 2023;676:66-72.
    PubMed     Abstract available


    June 2023
  102. LAN T, Wang W, Zeng XX, Tong YH, et al
    Saikosaponin A triggers cell ferroptosis in hepatocellular carcinoma by inducing endoplasmic reticulum stress-stimulated ATF3 expression.
    Biochem Biophys Res Commun. 2023;674:10-18.
    PubMed     Abstract available


  103. DU D, Wang S, Li T, Liu Z, et al
    RHNO1 disruption inhibits cell proliferation and induces mitochondrial apoptosis via PI3K/Akt pathway in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2023;673:96-105.
    PubMed     Abstract available


    May 2023
  104. JI S, Xu M, Cai C, He X, et al
    MESP1-knockdown inhibits the proliferation and epithelial mesenchymal transition of hepatocellular carcinoma and enhances the tumor-suppressive effect of 5-fluorouracil.
    Biochem Biophys Res Commun. 2023;670:1-11.
    PubMed     Abstract available


  105. AKL MG, Baccetto R, Stebbings BM, Li L, et al
    Euglycemia is affected by stress defense factor hepatocyte NRF1, but not NRF2.
    Biochem Biophys Res Commun. 2023;668:96-103.
    PubMed     Abstract available


  106. KHALIFA MO, Moriwaki T, Zhang S, Zhou W, et al
    Negative pressure induces dedifferentiation of hepatocytes via RhoA/ROCK pathway.
    Biochem Biophys Res Commun. 2023;667:104-110.
    PubMed     Abstract available


    April 2023
  107. UEHARA S, Higuchi Y, Yoneda N, Ito R, et al
    HepaSH cells: Experimental human hepatocytes with lesser inter-individual variation and more sustainable availability than primary human hepatocytes.
    Biochem Biophys Res Commun. 2023;663:132-141.
    PubMed     Abstract available


  108. LIN Y, Fang H, Ma C, Zhou J, et al
    ACLY-beta-catenin axis modulates hepatoblastoma cell proliferation.
    Biochem Biophys Res Commun. 2023;663:104-112.
    PubMed     Abstract available


  109. ZENG S, Tao M, Yuan L, Zhang L, et al
    Inhibition of mGluR5 ameliorates lipid accumulation and inflammation in HepG2 cells.
    Biochem Biophys Res Commun. 2023;653:1-11.
    PubMed     Abstract available


  110. CHEN L, Li Z, Wei W, An B, et al
    Human embryonic stem cell-derived immunity-and-matrix regulatory cells promote intrahepatic cell renewal to rescue acute liver failure.
    Biochem Biophys Res Commun. 2023;662:104-113.
    PubMed     Abstract available


  111. BI S, Zhang Y, Zhou J, Yao Y, et al
    miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K/AKT/mTOR signaling.
    Biochem Biophys Res Commun. 2023;662:47-57.
    PubMed     Abstract available


  112. LI L, Xiong Y, Cao W, Chen Z, et al
    Epidermal growth factor receptor promotes high-fructose nonalcoholic fatty liver disease by inducing mitochondrial fission in zebrafish.
    Biochem Biophys Res Commun. 2023;652:112-120.
    PubMed     Abstract available


  113. WANG Q, Peng X, Chen Y, Tang X, et al
    Piezo1 alleviates acetaminophen-induced acute liver injury by activating Nrf2 and reducing mitochondrial reactive oxygen species.
    Biochem Biophys Res Commun. 2023;652:88-94.
    PubMed     Abstract available


  114. ZHANG N, Guo F, Song Y
    HOXC8/TGF-beta1 positive feedback loop promotes liver fibrosis and hepatic stellate cell activation via activating Smad2/Smad3 signaling.
    Biochem Biophys Res Commun. 2023;662:39-46.
    PubMed     Abstract available


  115. KIM D, Choi I, Ha SK, Gonzalez FJ, et al
    Keratin 79 is a PPARA target that is highly expressed by liver damage.
    Biochem Biophys Res Commun. 2023;650:132-136.
    PubMed     Abstract available


  116. QIN Z, Wang P, Chen W, Wang JR, et al
    Hepatic ELOVL3 is dispensable for lipid metabolism in mice.
    Biochem Biophys Res Commun. 2023;658:128-135.
    PubMed     Abstract available


    March 2023
  117. CHO W, Choi SW, Oh H, Baygutalp F, et al
    Musclin attenuates lipid deposition in hepatocytes through SIRT7/autophagy-mediated suppression of ER stress.
    Biochem Biophys Res Commun. 2023;658:62-68.
    PubMed     Abstract available


  118. ZHU W, Dong X, Luo S, Guo S, et al
    Transcriptional activation of CSTB gene expression by transcription factor Sp3.
    Biochem Biophys Res Commun. 2023;649:71-78.
    PubMed     Abstract available


  119. ZHU C, Guo H, Ma Z, Shi S, et al
    FOXM1 augments sorafenib resistance and promotes progression of hepatocellular carcinoma by epigenetically activating KIF23 expression.
    Biochem Biophys Res Commun. 2023;656:1-9.
    PubMed     Abstract available


  120. GUO J, Duan H, Li Y, Yang L, et al
    Retraction notice to "A novel circular RNA circ-ZNF652 promotes hepatocellular carcinoma metastasis through inducing snail-mediated epithelial-mesenchymal transition by sponging miR-203/miR-502-5p" [YBBRC 513(4) (2019) 812-819].
    Biochem Biophys Res Commun. 2023 Mar 13:S0006-291X(23)00243.
    PubMed     Abstract available


  121. ANDO T, Ito D, Shiogama K, Sakai Y, et al
    Administration of spermidine attenuates concanavalin A-induced liver injury.
    Biochem Biophys Res Commun. 2023;648:44-49.
    PubMed     Abstract available


  122. NATU A, Pedgaonkar A, Gupta S
    Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines.
    Biochem Biophys Res Commun. 2023;648:1-10.
    PubMed     Abstract available


    February 2023
  123. YANG H, Wang Q, Zhang P, Cheng K, et al
    Preliminary mechanism of inhibitor of SGLT2 in fatty liver cold ischemia injury.
    Biochem Biophys Res Commun. 2023;646:96-102.
    PubMed     Abstract available


  124. ZENG R, Zeng Y, Wang Q, Li X, et al
    Sleeve gastrectomy decreased hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    Biochem Biophys Res Commun. 2023;653:115-125.
    PubMed     Abstract available


  125. LU Y, Wang M, Zhao M, Zhang Q, et al
    Filamin A is overexpressed in non-alcoholic steatohepatitis and contributes to the progression of inflammation and fibrosis.
    Biochem Biophys Res Commun. 2023;653:93-101.
    PubMed     Abstract available


  126. HE X, Chen F, Lu C, Wang S, et al
    Comparison of anti-tumor activities and underlying mechanisms of glucuronomannan oligosaccharides and its sulfated derivatives on the hepatocarcinoma Huh7.5 cells.
    Biochem Biophys Res Commun. 2023;652:103-111.
    PubMed     Abstract available


  127. KOU K, Li S, Qiu W, Fan Z, et al
    Hypoxia-inducible factor 1alpha/IL-6 axis in activated hepatic stellate cells aggravates liver fibrosis.
    Biochem Biophys Res Commun. 2023;653:21-30.
    PubMed     Abstract available


  128. HOU B, Qin L, Huang L
    Liver cancer cells as the model for developing liver-targeted RNAi therapeutics.
    Biochem Biophys Res Commun. 2023;644:85-94.
    PubMed     Abstract available


  129. AKI T, Kukita M, Takata M, Funakoshi T, et al
    Induction of and its involvement in the regulation of cellular senescence and apoptosis in Huh-7 hepatoma cells during exposure.
    Biochem Biophys Res Commun. 2023;651:92-97.
    PubMed     Abstract available


  130. NTAMBI JM, Liu X, Burhans MS, ALjohani A, et al
    Hepatic oleate regulates one-carbon metabolism during high carbohydrate feeding.
    Biochem Biophys Res Commun. 2023;651:62-69.
    PubMed     Abstract available


  131. ZHAO T, Han Z, Zhang J, Ding Y, et al
    Effect of ADHI on hepatic stellate cell activation and liver fibrosis in mice.
    Biochem Biophys Res Commun. 2023;651:98-106.
    PubMed     Abstract available


    January 2023
  132. CHO W, Choi SW, Oh H, Abd El-Aty AM, et al
    Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK/FGF21 signaling.
    Biochem Biophys Res Commun. 2023;648:59-65.
    PubMed     Abstract available


  133. XUE G, Zhang J, Wu L, Sun S, et al
    Differentiation of umbilical cord mesenchymal stem cells into hepatocytes with CYP450 metabolic enzyme activity induced by a liver injury microenvironment.
    Biochem Biophys Res Commun. 2023;647:47-54.
    PubMed     Abstract available


  134. JIANG Z, Sun H, Miao J, Sheng Q, et al
    The natural flavone acacetin protects against high-fat diet-induced lipid accumulation in the liver via the endoplasmic reticulum stress/ferroptosis pathway.
    Biochem Biophys Res Commun. 2023;640:183-191.
    PubMed     Abstract available


  135. YOU K, Wang Y, Chen X, Yang Z, et al
    Neutralizing serum amyloid a protects against sinusoidal endothelial cell damage and platelet aggregation during acetaminophen-induced liver injury.
    Biochem Biophys Res Commun. 2023;639:20-28.
    PubMed     Abstract available


    December 2022
  136. LI Y, Yin Y, He Y, He K, et al
    SOS1 regulates HCC cell epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway.
    Biochem Biophys Res Commun. 2022;637:161-169.
    PubMed     Abstract available


  137. AGGARWAL S, Yadav V, Maiwall R, Rastogi A, et al
    Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum.
    Biochem Biophys Res Commun. 2022;643:129-138.
    PubMed     Abstract available


  138. ZHANG J, Yang Z, Yan X, Duan J, et al
    RNA-binding protein SPEN controls hepatocyte maturation via regulating Hnf4alpha expression during liver development.
    Biochem Biophys Res Commun. 2022;642:128-136.
    PubMed     Abstract available


  139. WU K, Zou J, Sack MN
    The endo-lysosomal regulatory protein BLOC1S1 modulates hepatic lysosomal content and lysosomal lipolysis.
    Biochem Biophys Res Commun. 2022;642:1-10.
    PubMed     Abstract available


  140. SUN X, Yu Q, Kang B, Zhao X, et al
    Diethyldithiocarbamate inhibits the activation of hepatic stellate cells via PPARalpha/FABP1 in mice with non-alcoholic steatohepatitis.
    Biochem Biophys Res Commun. 2022;641:192-199.
    PubMed     Abstract available


  141. NTAMBI JM
    The role of Stearoyl-CoA desaturase in hepatic de novo lipogenesis.
    Biochem Biophys Res Commun. 2022;633:81-83.
    PubMed     Abstract available


  142. IWANAGA T, Chiba T, Nakamura M, Kaneko T, et al
    Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-beta/Smad pathway suppression in hepatic stellate cells.
    Biochem Biophys Res Commun. 2022;642:192-200.
    PubMed     Abstract available


  143. CHEN W, Ru J, Wu T, Man D, et al
    MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;640:1-11.
    PubMed     Abstract available


  144. ZHANG F, Wu J, Ruan H, Xia J, et al
    ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas.
    Biochem Biophys Res Commun. 2022;632:129-138.
    PubMed     Abstract available


  145. WU F, Tu C, Zhang K, Che H, et al
    Knockdown of PKMYT1 is associated with autophagy inhibition and apoptosis induction and suppresses tumor progression in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;640:173-182.
    PubMed     Abstract available


    November 2022
  146. LEI X, Hu X, Lu Q, Yao Y, et al
    UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc.
    Biochem Biophys Res Commun. 2022;638:210-218.
    PubMed     Abstract available


  147. ZHAO Q
    Mutant IDH1 attenuates hepatic lipogenesis through PTEN dependent pathway.
    Biochem Biophys Res Commun. 2022;637:254-258.
    PubMed     Abstract available


  148. KIM SQ, Mohallem R, Franco J, Buhman KK, et al
    Global landscape of protein complexes in postprandial-state livers from diet-induced obese and lean mice.
    Biochem Biophys Res Commun. 2022;629:40-46.
    PubMed     Abstract available


  149. DU X, Li H, Han X, Ma W, et al
    Mesenchymal stem cells-derived exosomal miR-24-3p ameliorates non-alcohol fatty liver disease by targeting Keap-1.
    Biochem Biophys Res Commun. 2022;637:331-340.
    PubMed     Abstract available


    October 2022
  150. WANG Q, Zheng K, Tan D, Liang G, et al
    TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;636.
    PubMed     Abstract available


  151. IQBAL T, Nawaz A, Karim M, Yaku K, et al
    Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease.
    Biochem Biophys Res Commun. 2022;636.
    PubMed     Abstract available


  152. LEE KM, Hwang YJ, Jung GS
    Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression.
    Biochem Biophys Res Commun. 2022;626:135-141.
    PubMed     Abstract available


  153. TIAN-QI C, Yan-Fang D, Yan-Yan W, Yong-Hui Z, et al
    Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-kappaB signaling pathway.
    Biochem Biophys Res Commun. 2022;626:167-174.
    PubMed     Abstract available


  154. LIN C, Yang H, Zhao W, Wang W, et al
    CTSB(+) macrophage repress memory immune hub in the liver metastasis site of colorectal cancer patient revealed by multi-omics analysis.
    Biochem Biophys Res Commun. 2022;626:8-14.
    PubMed     Abstract available


  155. OHKOSHI-YAMADA M, Kamimura K, Kimura A, Tanaka Y, et al
    Effects of a selective PPARalpha modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model.
    Biochem Biophys Res Commun. 2022;625:116-121.
    PubMed     Abstract available


  156. TU H, Yin X, Wen J, Wu W, et al
    Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism.
    Biochem Biophys Res Commun. 2022;634:1-9.
    PubMed     Abstract available


  157. HUANG Y, Liang W, Li K, Liao X, et al
    Sorafenib suppresses the activation of type I interferon pathway induced by RLR-MAVS and cGAS-STING signaling.
    Biochem Biophys Res Commun. 2022;623:181-188.
    PubMed     Abstract available


  158. CUI B, Yang L, Zhao Y, Lu X, et al
    HOXA13 promotes liver regeneration through regulation of BMP-7.
    Biochem Biophys Res Commun. 2022;623:23-31.
    PubMed     Abstract available


  159. SAMERI MJ, Savari F, Hoseinynejad K, Danyaei A, et al
    The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1.
    Biochem Biophys Res Commun. 2022;635:194-202.
    PubMed     Abstract available


    September 2022
  160. ZHAO S, Liu X, Li L, Kong X, et al
    KIRA8 attenuates non-alcoholic steatohepatitis through inhibition of the IRE1alpha/XBP1 signalling pathway.
    Biochem Biophys Res Commun. 2022;632:158-164.
    PubMed     Abstract available


  161. ZHANG W, Xue H, Zhou C, Zheng Z, et al
    7-aminocephalosporanic acid, a novel HSP90beta inhibitor, attenuates HFD-induced hepatic steatosis.
    Biochem Biophys Res Commun. 2022;622:184-191.
    PubMed     Abstract available


  162. ZHONG F, Chen T, Li B
    Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling.
    Biochem Biophys Res Commun. 2022;622:170-176.
    PubMed     Abstract available


  163. MAO X, Wu D, Xu N, Wang J, et al
    The danger signal interferon-induced protein 35 (IFP35) mediates acetaminophen-induced liver injury.
    Biochem Biophys Res Commun. 2022;621:25-31.
    PubMed     Abstract available


  164. SUN TT, Liu XL, Yang GY, Zhang W, et al
    Neurotrophic factors stimulate the activation of hepatic stellate cells in liver fibrosis.
    Biochem Biophys Res Commun. 2022;630:167-174.
    PubMed     Abstract available


  165. XU Y, Lu Y
    Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPARalpha-mediated regulation of adipose tissue mass.
    Biochem Biophys Res Commun. 2022;619:84-89.
    PubMed     Abstract available


    August 2022
  166. CHU K, Zhao N, Hu X, Feng R, et al
    LncNONMMUG027912 alleviates lipid accumulation through AMPKalpha/mTOR/SREBP1C axis in nonalcoholic fatty liver.
    Biochem Biophys Res Commun. 2022;618:8-14.
    PubMed     Abstract available


  167. LEI X, Dai X, Wang Q, Long R, et al
    RNA-seq transcriptome profiling of liver regeneration in mice identifies the miR-34b-5p/phosphoinositide-dependent protein kinase 1 axis as a potential target for hepatocyte proliferation.
    Biochem Biophys Res Commun. 2022;627:111-121.
    PubMed     Abstract available


  168. LU Z, Yang H, Shao Y, Sun W, et al
    IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;627:103-110.
    PubMed     Abstract available


  169. JIA M, Xiao Y, Zhang C, Jiang T, et al
    Mitoxantrone alleviates hepatic steatosis induced by high-fat diet in broilers.
    Biochem Biophys Res Commun. 2022;627:52-59.
    PubMed     Abstract available


  170. PEI Y, Balogun O, Otieno D, Parks JS, et al
    The effects of brewers' spent grain on high-fat diet-induced fatty liver.
    Biochem Biophys Res Commun. 2022;616:49-55.
    PubMed     Abstract available


  171. CHEN Y, Zhang X
    TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2022;625:23-30.
    PubMed     Abstract available


    July 2022
  172. LI L, Li S, Wang H, Li L, et al
    GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2022;625:109-115.
    PubMed     Abstract available


  173. MORI J, Sawada T, Baba T, Hayakawa A, et al
    Identification of cell cycle-associated and -unassociated regulators for expression of a hepatocellular carcinoma oncogene cyclin-dependent kinase inhibitor 3.
    Biochem Biophys Res Commun. 2022;625:46-52.
    PubMed     Abstract available


  174. ZHOU J, Liu T, Xu H, Wang Y, et al
    LncRNA FIRRE promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the expression of PXN through interacting with MBNL3.
    Biochem Biophys Res Commun. 2022;625:188-195.
    PubMed     Abstract available


  175. ZHANG X, Tao X, Feng F
    Downregulation of C12orf75 gene inhibits migration and invasion of liver cancer cell via suppressing the Wnt/beta-catenin signaling pathway in vitro.
    Biochem Biophys Res Commun. 2022;614:92-99.
    PubMed     Abstract available


  176. TANG C, Qiu S, Mou W, Xu J, et al
    Excessive activation of HOXB13/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance.
    Biochem Biophys Res Commun. 2022;623:81-88.
    PubMed     Abstract available


  177. HU X, Pan H, Zhou S, Pang Q, et al
    HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression.
    Biochem Biophys Res Commun. 2022;623:111-119.
    PubMed     Abstract available


  178. XU M, Wu X, Liu Z, Ding Y, et al
    A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
    Biochem Biophys Res Commun. 2022;622:163-169.
    PubMed     Abstract available


  179. GUO B, Xu X, Shao M, Yang X, et al
    UDP-glucose 6-dehydrogenase lessens sorafenib sensitivity via modulating unfolded protein response.
    Biochem Biophys Res Commun. 2022;613:207-213.
    PubMed     Abstract available


  180. XU Y, Denning KL, Lu Y
    PPARalpha agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
    Biochem Biophys Res Commun. 2022;613:47-52.
    PubMed     Abstract available


  181. TOYOTA A, Goto M, Miyamoto M, Nagashima Y, et al
    Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.
    Biochem Biophys Res Commun. 2022;621:157-161.
    PubMed     Abstract available


    June 2022
  182. HONG W, Peng X, Zhou X, Li P, et al
    FXR/ASS1 axis attenuates the TAA-induced liver injury through arginine metabolism.
    Biochem Biophys Res Commun. 2022;611:31-37.
    PubMed     Abstract available


  183. MENG J, Zhang C, Wang D, Zhu L, et al
    Mitochondrial GCN5L1 regulates cytosolic redox state and hepatic gluconeogenesis via glycerol phosphate shuttle GPD2.
    Biochem Biophys Res Commun. 2022;621:1-7.
    PubMed     Abstract available


  184. GAO L, Zhang Y, Gao X, Xu L, et al
    Methylation of the HCBP6 promoter is associated with primary biliary cholangitis pathogenesis.
    Biochem Biophys Res Commun. 2022;610:176-181.
    PubMed     Abstract available


  185. KE X, Zhang R, Li P, Zuo L, et al
    Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating inflammation and lipid metabolism.
    Biochem Biophys Res Commun. 2022;610:49-55.
    PubMed     Abstract available


  186. JUNG SY, Yun HH, Lim JH, Lee DH, et al
    Hepatocyte-specific deletion of Bis causes senescence in the liver without deteriorating hepatic function.
    Biochem Biophys Res Commun. 2022;619:42-48.
    PubMed     Abstract available


  187. CAI Q, Zhu J, Cui X, Xia Y, et al
    S100A9 promotes inflammatory response in diabetic nonalcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;618:127-132.
    PubMed     Abstract available


  188. LI S, Wang Y, Dun W, Han W, et al
    Phosphoproteomic analysis of FAC overload-triggered human hepatic cells reveals G2/M phase arrest.
    Biochem Biophys Res Commun. 2022;619:62-67.
    PubMed     Abstract available


  189. SAKURAI M, Weber P, Wolff G, Wieder A, et al
    TSC22D4 promotes TGFbeta1-induced activation of hepatic stellate cells.
    Biochem Biophys Res Commun. 2022;618:46-53.
    PubMed     Abstract available


  190. WU W, Lu P, Huang Y, Zhu Z, et al
    Emodin regulates the autophagy via the miR-371a-5p/PTEN axis to inhibit hepatic malignancy.
    Biochem Biophys Res Commun. 2022;619:1-8.
    PubMed     Abstract available


  191. FAN K, Zan X, Zhi Y, Yang Y, et al
    Immune response gene 1 deficiency impairs Nrf2 activation and aggravates liver fibrosis in mice.
    Biochem Biophys Res Commun. 2022;607:103-109.
    PubMed     Abstract available


  192. OH HA, Kim YJ, Moon KS, Seo JW, et al
    Identification of integrative hepatotoxicity induced by lysosomal phospholipase A2 inhibition of cationic amphiphilic drugs via metabolomics.
    Biochem Biophys Res Commun. 2022;607:1-8.
    PubMed     Abstract available


  193. HUANG L, He X, Peng W, He X, et al
    Hyperuricemia induces liver injury by upregulating HIF-1alpha and inhibiting arginine biosynthesis pathway in mouse liver and human L02 hepatocytes.
    Biochem Biophys Res Commun. 2022;617.
    PubMed     Abstract available


    May 2022
  194. MA Y, Li Q, Chen G, Tan Z, et al
    Transcriptomic analysis reveals a novel regulatory factor of ECHDC1 involved in lipid metabolism of non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;605:1-8.
    PubMed     Abstract available


  195. YOKOBORI K, Gruzdev A, Negishi M
    Mice blocking Ser347 phosphorylation of pregnane x receptor develop hepatic fasting-induced steatosis and hypertriglyceridemia.
    Biochem Biophys Res Commun. 2022;615:75-80.
    PubMed     Abstract available


  196. WEN H, He R, Wang H, Zhao S, et al
    Effects of small molecule inhibitor SW033291 on hepatic ischemia-reperfusion injury in mice.
    Biochem Biophys Res Commun. 2022;615:70-74.
    PubMed     Abstract available


  197. LI J, Huang L, Xiong W, Qian Y, et al
    Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway.
    Biochem Biophys Res Commun. 2022;603:35-40.
    PubMed     Abstract available


    April 2022
  198. LIU Q, Tang Q, Jing X, Zhang J, et al
    Mesencephalic astrocyte-derived neurotrophic factor protects against paracetamol -induced liver injury by inhibiting PERK-ATF4-CHOP signaling pathway.
    Biochem Biophys Res Commun. 2022;602:163-169.
    PubMed     Abstract available


  199. FUKUCHI T, Ueno T, Yamamoto T, Noguchi T, et al
    Liver progenitor cells may construct cysts having heterogeneous gene expression of liver-enriched transcription factors in mice with conditional knockout of the Hhex gene.
    Biochem Biophys Res Commun. 2022;602:49-56.
    PubMed     Abstract available


  200. ZHANG X, An T, Zhang X, Shen T, et al
    DDX17 protects hepatocytes against oleic acid/palmitic acid-induced lipid accumulation.
    Biochem Biophys Res Commun. 2022;612:169-175.
    PubMed     Abstract available


  201. LIAO C, Zhang L, Jiang R, Xu J, et al
    Inhibition of NAD kinase elevates the hepatic NAD(+) pool and alleviates acetaminophen-induced acute liver injury in mice.
    Biochem Biophys Res Commun. 2022;612:70-76.
    PubMed     Abstract available


  202. XIAO F, Xu F, Zhang H, Shuai X, et al
    Circ_0000591 served as endogenous RNA for miR-326 to promote progression of cholangiocarcinoma via the TLR4/MyD88/IL6 axis.
    Biochem Biophys Res Commun. 2022;600:101-108.
    PubMed     Abstract available


  203. WANG R, Ren Y, Bao T, Wang T, et al
    Inulin activates FXR-FGF15 signaling and further increases bile acids excretion in non-alcoholic fatty liver disease mice.
    Biochem Biophys Res Commun. 2022;600:156-162.
    PubMed     Abstract available


  204. EL-ASHMAWY NE, Khedr NF, Sallam M, Nossier AI, et al
    Effect of activation of liver X receptor alpha on cardiac & hepatic ABCC10 and SLC17A5 drug transporters in hypercholesterolemic rat model.
    Biochem Biophys Res Commun. 2022;610:133-139.
    PubMed     Abstract available


  205. XU ZX, Li JZ, Li Q, Xu MY, et al
    CircRNA608-microRNA222-PINK1 axis regulates the mitophagy of hepatic stellate cells in NASH related fibrosis.
    Biochem Biophys Res Commun. 2022;610:35-42.
    PubMed     Abstract available


  206. JUNG TW, Jeong JC, Park SY, Cho W, et al
    Abietic acid alleviates endoplasmic reticulum stress and lipid accumulation in human primary hepatocytes through the AMPK/ORP150 signaling.
    Biochem Biophys Res Commun. 2022;608:142-148.
    PubMed     Abstract available


  207. AI L, Wang Q, Cheng K
    Key genes in the liver fibrosis process are mined based on single-cell transcriptomics.
    Biochem Biophys Res Commun. 2022;598:131-137.
    PubMed     Abstract available


    March 2022
  208. FUNATO K, Otsuka M, Sekiba K, Miyakawa Y, et al
    Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors.
    Biochem Biophys Res Commun. 2022;607:89-95.
    PubMed     Abstract available


  209. YAN H, He N, He S
    HCG15 is a hypoxia-responsive lncRNA and facilitates hepatocellular carcinoma cell proliferation and invasion by enhancing ZNF641 transcription.
    Biochem Biophys Res Commun. 2022;608:170-176.
    PubMed     Abstract available


  210. NHO B, Ko KR, Kim S, Lee J, et al
    Intramuscular injection of a plasmid DNA vector expressing hepatocyte growth factor (HGF) ameliorated pain symptoms by controlling the expression of pro-inflammatory cytokines in the dorsal root ganglion.
    Biochem Biophys Res Commun. 2022;607:60-66.
    PubMed     Abstract available


  211. CHEN Z, Liu S, Xie P, Zhang B, et al
    Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro.
    Biochem Biophys Res Commun. 2022;605:82-89.
    PubMed     Abstract available


  212. SHU Z, Zhang G, Zhu X, Xiong W, et al
    Estrogen receptor alpha mediated M1/M2 macrophages polarization plays a critical role in NASH of female mice.
    Biochem Biophys Res Commun. 2022;596:63-70.
    PubMed     Abstract available


  213. CHEN R, Luo X, Jiang X, Deng S, et al
    Vinexin beta deficiency exacerbates diet-induced obesity, hepatosteatosis, insulin resistance and endoplasmic reticulum stress in mice.
    Biochem Biophys Res Commun. 2022;596:14-21.
    PubMed     Abstract available


  214. CHEN Q, Huang J, Tong W, Gui X, et al
    The geometry-dependent regulation of hepatic stellate cells by graphene oxide nanomaterials.
    Biochem Biophys Res Commun. 2022;604:179-184.
    PubMed     Abstract available


  215. ZHANG C, Lin J, Zhen C, Wang F, et al
    Amygdalin protects against acetaminophen-induced acute liver failure by reducing inflammatory response and inhibiting hepatocyte death.
    Biochem Biophys Res Commun. 2022;602:105-112.
    PubMed     Abstract available


    February 2022
  216. LI X, Yang M, Sun H, Ferdous MRU, et al
    Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation.
    Biochem Biophys Res Commun. 2022;594:168-176.
    PubMed     Abstract available


  217. SHI C, Pei M, Wang Y, Chen Q, et al
    Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.
    Biochem Biophys Res Commun. 2022;594:1-7.
    PubMed     Abstract available


  218. O G, Cascione S, Michielin F, Elvassore N, et al
    The emergence of the circadian clock network in hiPSC-derived hepatocytes on chip.
    Biochem Biophys Res Commun. 2022;601:109-115.
    PubMed     Abstract available


  219. YAMAGUCHI M, Ohbayashi S, Ooka A, Yamashita H, et al
    Harmine suppresses collagen production in hepatic stellate cells by inhibiting DYRK1B.
    Biochem Biophys Res Commun. 2022;600:136-141.
    PubMed     Abstract available


    January 2022
  220. QIAN M, Cao S, Wang T, Xu X, et al
    Apoptosis triggered by cytolethal distending toxin B subunit of Helicobacter hepaticus is aggravated by autophagy inhibition in mouse hepatocytes.
    Biochem Biophys Res Commun. 2022;598:40-46.
    PubMed     Abstract available


  221. KIMURA A, Kamimura K, Ohkoshi-Yamada M, Shinagawa-Kobayashi Y, et al
    Effects of a novel selective PPARalpha modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model.
    Biochem Biophys Res Commun. 2022;596:76-82.
    PubMed     Abstract available


  222. WANG M, Li B, Qin F, Ye J, et al
    Obesity induced Ext1 reduction mediates the occurrence of NAFLD.
    Biochem Biophys Res Commun. 2022;589:123-130.
    PubMed     Abstract available


  223. LEE N, Heo YJ, Choi SE, Jeon JY, et al
    Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;588:154-160.
    PubMed     Abstract available


  224. KANDA Y, Ohata H, Miyazaki T, Sakai H, et al
    NF-kappaB suppression synergizes with E7386, an inhibitor of CBP/beta-catenin interaction, to block proliferation of patient-derived colon cancer spheroids.
    Biochem Biophys Res Commun. 2022;586:93-99.
    PubMed     Abstract available


    December 2021
  225. JUN H, ZeXin Z
    Screening of pyroptosis-related genes influencing the therapeutic effect of dehydroabietic acid in liver cancer and construction of a survival nomogram.
    Biochem Biophys Res Commun. 2021;585:103-110.
    PubMed     Abstract available


  226. CANG X, Wang Y, Zeng J, Gao J, et al
    C9orf72 knockdown alleviates hepatic insulin resistance by promoting lipophagy.
    Biochem Biophys Res Commun. 2021;588:15-22.
    PubMed     Abstract available


  227. LIU Z, Ma C, Wang Q, Yang H, et al
    Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;589:247-253.
    PubMed     Abstract available


    November 2021
  228. SHI Y, Wei Q, Liu Y, Yuan J, et al
    The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver.
    Biochem Biophys Res Commun. 2021;580:1-6.
    PubMed     Abstract available


  229. ZHANG WW, Xue R, Mi TY, Shen XM, et al
    Propofol ameliorates acute postoperative fatigue and promotes glucagon-regulated hepatic gluconeogenesis by activating CREB/PGC-1alpha and accelerating fatty acids beta-oxidation.
    Biochem Biophys Res Commun. 2021;586:121-128.
    PubMed     Abstract available


  230. SZTOLSZTENER K, Harasim-Symbor E, Chabowski A, Konstantynowicz-Nowicka K, et al
    The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
    Biochem Biophys Res Commun. 2021;585:132-138.
    PubMed     Abstract available


  231. LI Y, Dong J, Zhou Y, Ye X, et al
    Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats.
    Biochem Biophys Res Commun. 2021;584:87-94.
    PubMed     Abstract available


    October 2021
  232. LIU H, Wang M, Jin Z, Sun D, et al
    FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARgamma/NF-kappaB/NLRP3 pathway.
    Biochem Biophys Res Commun. 2021;582:77-85.
    PubMed     Abstract available


  233. FANG J, Liang W
    ASCs -derived exosomes loaded with vitamin A and quercetin inhibit rapid senescence-like response after acute liver injury.
    Biochem Biophys Res Commun. 2021;572:125-130.
    PubMed     Abstract available


    September 2021
  234. CHO J, Tsugawa Y, Imai Y, Imai T, et al
    Chorionic gonadotropin stimulates maternal hepatocyte proliferation during pregnancy.
    Biochem Biophys Res Commun. 2021;579:110-115.
    PubMed     Abstract available


  235. XU L, Yang C, Wang J, Li Z, et al
    Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Biochem Biophys Res Commun. 2021;578:142-149.
    PubMed     Abstract available


  236. JIN Y, Yang R, Ding J, Zhu F, et al
    KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP.
    Biochem Biophys Res Commun. 2021;585:185-190.
    PubMed     Abstract available


    August 2021
  237. HUANG T, Yu J, Luo Z, Yu L, et al
    Translatome analysis reveals the regulatory role of betaine in high fat diet (HFD)-induced hepatic steatosis.
    Biochem Biophys Res Commun. 2021;575:20-27.
    PubMed     Abstract available


  238. WANG Z, Qu K, Zhou L, Ren L, et al
    Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2021;577:45-51.
    PubMed     Abstract available


  239. CHEN B, Cha JH, Yan M, Cao N, et al
    ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin.
    Biochem Biophys Res Commun. 2021;573:1-8.
    PubMed     Abstract available


    July 2021
  240. KIM H, Lee JY, Park SJ, Kwag E, et al
    ZNF746/PARIS promotes the occurrence of hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;563:98-104.
    PubMed     Abstract available


  241. LIU P, Xia P, Fu Q, Liu C, et al
    miR-199a-5p inhibits the proliferation of hepatocellular carcinoma cells by regulating CDC25A to induce cell cycle arrest.
    Biochem Biophys Res Commun. 2021;571:96-103.
    PubMed     Abstract available


  242. LEILEI L, Xue S, Yan L, Yuyuan L, et al
    PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-beta1.
    Biochem Biophys Res Commun. 2021;569:125-131.
    PubMed     Abstract available


    June 2021
  243. HE Y, Pei JH, Li XQ, Chi G, et al
    IL-35 promotes EMT through STAT3 activation and induces MET by promoting M2 macrophage polarization in HCC.
    Biochem Biophys Res Commun. 2021;559:35-41.
    PubMed     Abstract available


  244. YU HM, Chung HK, Park KS
    The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
    Biochem Biophys Res Commun. 2021;558:57-63.
    PubMed     Abstract available


  245. LIU C, Huang XY, Huang Y
    FAM83G promotes proliferation, invasion, and metastasis by regulating PI3K/AKT signaling in hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2021;567:63-71.
    PubMed     Abstract available


  246. OUYANG X, Yao L, Liu G, Liu S, et al
    Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.
    Biochem Biophys Res Commun. 2021;557:26-32.
    PubMed     Abstract available


  247. LI Y, Yi Q, Liao X, Han C, et al
    Hypomethylation-driven overexpression of HJURP promotes progression of hepatocellular carcinoma and is associated with poor prognosis.
    Biochem Biophys Res Commun. 2021;566:67-74.
    PubMed     Abstract available


  248. MA Y, Sun W, Zhang Q, Gao B, et al
    lncRNA BSG-AS1 is hypoxia-responsive and promotes hepatocellular carcinoma by enhancing BSG mRNA stability.
    Biochem Biophys Res Commun. 2021;566:101-107.
    PubMed     Abstract available


  249. ZENG Z, Shi Z, Liu Y, Zhao J, et al
    HIF-1alpha-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Biochem Biophys Res Commun. 2021;566:80-86.
    PubMed     Abstract available


  250. SATO T, Tsuchiya A, Owaki T, Kumagai M, et al
    Severe steatosis and mild colitis are important for the early occurrence of hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2021;566:36-44.
    PubMed     Abstract available


    May 2021
  251. WANG Y, Yang H, Zhang G, Luo C, et al
    hsa-miR-7-5p suppresses proliferation, migration and promotes apoptosis in hepatocellular carcinoma cell lines by inhibiting SPC24 expression.
    Biochem Biophys Res Commun. 2021;561:80-87.
    PubMed     Abstract available


  252. YUAN Y, Yuan HF, Geng Y, Zhao LN, et al
    Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells.
    Biochem Biophys Res Commun. 2021;560:172-178.
    PubMed     Abstract available


  253. PHO-IAM T, Punnakitikashem P, Somboonyosdech C, Sripinitchai S, et al
    PLGA nanoparticles containing alpha-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line.
    Biochem Biophys Res Commun. 2021;553:191-197.
    PubMed     Abstract available


  254. GOTO N, Shibutani S, Miura N, Watanabe R, et al
    Thapsigargin suppresses alpha 1-acid glycoprotein secretion independently of N-glycosylation and ER stress.
    Biochem Biophys Res Commun. 2021;552:30-36.
    PubMed     Abstract available


  255. ZHANG Q, Yang M, Qu Z, Zhou J, et al
    Corrigendum to Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo" [Biochem. Biophys. Res. Commun. (2016) 480(3) 334-340].
    Biochem Biophys Res Commun. 2021 May 5. pii: S0006-291X(21)00735.
    PubMed    


  256. YANG X, Yao B, Niu Y, Chen T, et al
    Corrigendum to hypoxia-induced lncRNA EIF3J-AS1 accelerates hepatocellular carcinoma progression via targeting miR-122-5p/CTNND2 axis.
    Biochem Biophys Res Commun. 2021 May 5. pii: S0006-291X(21)00729.
    PubMed    


    April 2021
  257. OHYA K, Imamura M, Teraoka Y, Uchida T, et al
    Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted mice.
    Biochem Biophys Res Commun. 2021;559:78-83.
    PubMed     Abstract available


  258. YAN L, Zhang X, Fu J, Liu Q, et al
    Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis.
    Biochem Biophys Res Commun. 2021;558:86-93.
    PubMed     Abstract available


  259. ZHANG H, Yao W, Zhang M, Lu Y, et al
    TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.
    Biochem Biophys Res Commun. 2021;550:84-91.
    PubMed     Abstract available


  260. WANG TT, Hong YF, Chen ZH, Wu DH, et al
    Synergistic effects of alpha-Mangostin and sorafenib in hepatocellular carcinoma: New insights into alpha-mangostin cytotoxicity.
    Biochem Biophys Res Commun. 2021;558:14-21.
    PubMed     Abstract available


  261. KATO T, Murata D, Anders RA, Sesaki H, et al
    Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.
    Biochem Biophys Res Commun. 2021;549:83-90.
    PubMed     Abstract available


  262. YOSHINO K, Hosooka T, Shinohara M, Aoki C, et al
    Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2.
    Biochem Biophys Res Commun. 2021;557:62-68.
    PubMed     Abstract available


  263. LI G, Du P, He J, Li Y, et al
    CircRNA circBACH1 (hsa_circ_0061395) serves as a miR-656-3p sponge to facilitate hepatocellular carcinoma progression through increasing SERBP1 expression.
    Biochem Biophys Res Commun. 2021;556:1-8.
    PubMed     Abstract available


  264. WU M, Chen P, Liu F, Lv B, et al
    ONX0912, a selective oral proteasome inhibitor, triggering mitochondrial apoptosis and mitophagy in liver cancer.
    Biochem Biophys Res Commun. 2021;547:102-110.
    PubMed     Abstract available


  265. LI D, Xie P, Zhao S, Zhao J, et al
    Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD.
    Biochem Biophys Res Commun. 2021;555:54-60.
    PubMed     Abstract available


    March 2021
  266. FAN Z, Gao Y, Zhang W, Yang G, et al
    METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC.
    Biochem Biophys Res Commun. 2021;546:169-177.
    PubMed     Abstract available


  267. PARK NY, Jo DS, Park SJ, Lee H, et al
    Depletion of HNRNPA1 induces peroxisomal autophagy by regulating PEX1 expression.
    Biochem Biophys Res Commun. 2021;545:69-74.
    PubMed     Abstract available


  268. XIN Y, Xu L, Zhang X, Yang C, et al
    Sirtuin 6 ameliorates alcohol-induced liver injury by reducing endoplasmic reticulum stress in mice.
    Biochem Biophys Res Commun. 2021;544:44-51.
    PubMed     Abstract available


    February 2021
  269. ZHANG Y, Sun Y, Zhang Y, Miao Q, et al
    Nuclear factor Y participates in alcoholic liver disease by activating SREBP1 expression in mice.
    Biochem Biophys Res Commun. 2021;541:90-94.
    PubMed     Abstract available


  270. YANG M, Cui Y, Song J, Cui C, et al
    Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1.
    Biochem Biophys Res Commun. 2021;546:74-82.
    PubMed     Abstract available


    January 2021
  271. XIAO T, Cui Y, Ji H, Yan L, et al
    Baicalein attenuates acute liver injury by blocking NLRP3 inflammasome.
    Biochem Biophys Res Commun. 2021;534:212-218.
    PubMed     Abstract available


  272. LI Y, Xia J, Shao F, Zhou Y, et al
    Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
    Biochem Biophys Res Commun. 2021;534:877-884.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.